Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery

Circulation

Volumn 100, Issue 19 SUPPL., 1999, Pages

  Belhomme, Denis ^a   Peynet, Jacqueline ^a   Louzy, Moez ^a   Launay, Jean Marie ^a   Kitakaze, Masafumi ^b   Menasché, Philippe ^a,c  

^a HÔPITAL LARIBOISIÈRE   (France)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c Hoptial Laribosière ^*  (France)

Author keywords

Anesthesia; Bypass; Ischemia

Indexed keywords

ANESTHETIC AGENT; FENTANYL; FLUNITRAZEPAM; ISOFLURANE; PANCURONIUM;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY SURGERY; FEMALE; HEART MUSCLE BIOPSY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; INHALATION ANESTHESIA; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; PRIORITY JOURNAL;

AGED; ANESTHETICS, INHALATION; CORONARY ARTERY BYPASS; FEMALE; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; ISOFLURANE; MALE; MIDDLE AGED;

EID: 0345201782     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Perrault LP, Menasché P, Bel A, de Chaumaray T, Peynet J, Mondry A, Olivero P, Emanoil-Ravier R, Moalic JM. Ischemic preconditioning in cardiac surgery: a word of caution. J Thorac Cardiovasc Surg. 1996;112: 1378-1386.
2. Cremer J, Steinhoff G, Karck M, Ahnsell T, Brandt M, Teebken OE, Hollander D, Haverich A. Ischemic preconditioning prior to myocardial protection with cold blood cardioplegia in coronary surgery. Eur J Cardiothorac Surg. 1997;12:753-758.
3. Kaukoranta PK, Lepojärvi MPK, Ylitalo KV, Kiviluoma KT, Peuhkurinen DJ. Normothermic retrograde blood cardioplegia with or without preceding ischemic preconditioning. Ann Thorac Surg. 1997;63: 1268-1274.
4. Sugden PH, Clerk A. "Stress-responsive" mitogen-activated protein kinases (c-Jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium. Circ Res. 1998;83:345-352.
5. Simkhovich BZ, Przyklenk K, Kloner RA. Role of protein kinase C as a cellular mediator of ischemic preconditioning: a critical review. Cardiovasc Res. 1998;40:9-22.
6. + channels: possible mechanism of cardioprotection. Circ Res. 1997;81: 1072-1082.
7. + channels by protein kinase C. Circ Res. 1998;83:110-114.
8. ATP channels: reduction of myocardial infarct size with an acute memory phase. Anesthesiology. 1997;87:361-370.
9. Cope DK, Impastato WK, Cohen MV, Downey JM. Volatile anesthetics protect the ischemic rabbit myocardium from infarction. Anesthesiology. 1997;86:699-709.
10. Cason BA, Gamperl AK, Slocum RE, Hickey RF. Anesthetic-induced preconditioning: previous administration of isoflurane decreases myocardial infarct size in rabbits. Anesthesiology. 1997;87:1182-1190.
11. Kitakaze M, Hori M, Morioka T, Minamino T, Takashima S, Sato H, Shinozaki Y, Chujo M, Mori H, Inoue M, Kamada T. Infarct size-limiting effect of ischemic preconditioning is blunted by inhibition of 5′-nucleotidase activity and attenuation of adenosine release. Circulation. 1994;89:1237-1246.
12. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem. 1951;193:265-275.
13. Cohen G, Shirai T, Weisel RD, Rao V, Merante F, Tumiati LC, Mohabeer MK, Borger MA, Li RK, Mickle DAG. Optimal myocardial preconditioning in a human model of ischemia and reperfusion. Circulation. 1998;98(suppl II):II-184-II-96.
14. + channel? Studies of contractile function after simulated ischemia in an atrial in vitro model. Circ Res. 1995;77:1030-1035.
15. 1-Adrenoceptor activation increases ecto-5′-nucleotidase activity and adenosine release in rat cardiomyocytes by activating protein kinase C. Circulation. 1995;91:2226-2234.
16. Kitakaze M, Funaya H, Minamino T, Node K, Sato H, Ueda Y, Okuyama Y, Kuzuya T, Mori M, Yoshida K. Role of protein kinase C-alpha in activation of ecto-5′-nucleotidase in the preconditioned canine myocardium. Biochem Biophys Res Commun. 1997;239:171-175.
17. Kitakaze M, Hori M, Takashima S, Sato H, Inoue M, Kamada T. Ischemic preconditioning increases adenosine release and 5′-nucleotidase activity during myocardial ischemia and reperfusion in dogs: implications for myocardial salvage. Circulation. 1993;87:208-215.
18. Minamino T, Kitakaze M, Morioka T, Node K, Komamura K, Takeda H, Inoue M, Hori M, Kamada T. Cardioprotection due to preconditioning correlates with increased ecto-5′-nucleotidase activity. Am J Physiol. 1996;270:H238-H244.
19. Miki T, Miura T, Bünger R, Suzuki K, Sakamoto J, Shimamoto K. Ecto-5′-nucleotidase is not required for ischemic preconditioning in rabbit myocardium in situ. Am J Physiol. 1998;275:H1329-H1337.
20. Van Wylen DGL. Effect of ischemic preconditioning on interstitial purine metabolite and lactate accumulation during myocardial ischemia. Circulation. 1994;89:2283-2289.
21. Kersten JR, Orth KG, Pagel PS, Mei DA, Gross GJ, Warltier DC. Role of adenosine in isoflurane-induced cardioprotection. Anesthesiology. 1997; 86:1128-1139.
22. ATP channel opener: effects on interstitial adenosine in dogs. J Mol Cell Cardiol. 1998;30: 1225-1236.
23. Tomai F. Ischemic preconditioning during coronary angioplasty. In: Marber MS, Yellon DM, eds. Ischemia, Preconditioning and Adaptation. Oxford, UK: Bios Scientific Publishers; 1996:163-185.
24. Seung-Jun O, Monty MH, Crawfort FA, Spinale FG. Protein kinase C activation before cardioplegic arrest: beneficial effects on myocyte contractility. J Thorac Cardiovasc Surg. 1997;114:651-659.
25. Rohs TJ, Kilgore KS, Georges AJ, Bolling SF. Postischemic function and protein kinase C signal transduction. Ann Thorac Surg. 1998;65: 1680-1684.
26. Cleveland JC, Meldrum DR, Cain BS, Banerjee A, Harken AH. Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium: two paradoxes revisited. Circulation. 1997;96: 29-32.
27. + channels in rabbit ventricular myocytes. Biochem Biophys Res Commun. 1996;229:852-856.
28. + channels. Am J Physiol. 1996;270:H1744-H1756.
29. Etievent JP, Chocron S, Toubin G, Taberlet C, Alwan K, Clement F, Cordier A, Schipman N, Kantelip JP. Use of cardiac troponin I as a marker of perioperative myocardial ischemia. Ann Thorac Surg. 1995; 59:1192-1194.
30. Sadony V, Köber M, Albes G, Podtschaske V, Etgen T, Trösken T, Ravens U, Scheulen ME. Cardiac troponin I plasma levels for diagnosis and quantitation of perioperative myocardial damage in patients undergoing coronary artery bypass surgery. Eur J Cardiothorac Surg. 1998;13:57-65.
31. Jacquet L, Noirhomme P, El Khoury G, Goenen M, Philippe M, Col J, Dion R. Cardiac troponin I as an early marker of myocardial damage after coronary bypass surgery. Eur J Cardiothorac Surg. 1998;13:378-384.
32. Skladanowski AC, Smolenski RT, Tavenier M, De Jong JW, Yacoub MH, Seymour AML. Soluble forms of 5′-nucleotidase in rat and human heart. Am J Physiol. 1996;270:H1493-H1500.
33. ATP) channels. Anesthesiology. 1996; 85:794-807.
34. Burns PG, Krukenkamp I, Caldarone CA, Gaudette GR, Bukhari EA, Levitsky S. Does cardiopulmonary bypass alone elicit myoprotective preconditioning? Circulation. 1995;92(suppl II):II-447-II-451.
35. El Schultz JJ, Hsu AK, Gross GJ. Morphine mimics the cardioprotective effects of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res. 1996;78:1100-1104.